Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects (MYSTICOL)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
US WorldMeds LLC Identifier:
First received: November 14, 2013
Last updated: October 4, 2016
Last verified: October 2016